Dr George Follows from Cambridge University Hospital, Cambridge, UK, talks about the toxicity profile of the emerging drugs in the field of chronic lymphocytic leukaemia (CLL).
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL.
This programme has been supported by AbbVie, through an unrestricted educational grant to the Patient Empowerment Foundation.
